Latest in News & Research
Rash, Itch After COVID Vaccine Rare & Quickly Resolves
By Robert Preidt (HealthDay News) | | June 23, 2021
Medicaid Enrollment Reaches Record High During Pandemic
Surge in enrollment during pandemic means that a quarter of the U.S. population is now covered by the public program
By Physician's Briefing Staff | | June 22, 2021
Poll: Many 'High-Risk' Americans Unconcerned About Skin Cancer
AAD survey revealed that 49 percent of respondents were more worried about avoiding sunburn than preventing skin cancer
By Physician’s Briefing Staff | | June 22, 2021
Risk Factors for PHACE Syndrome ID'd in Infantile Hemangiomas
Surface area of 25 cm
By Physician’s Briefing Staff | | June 17, 2021
Animal Study Offers Hope for a Better Herpes Treatment
By Alan Mozes (HealthDay News) | | June 17, 2021
Skin Rashes May Indicate Positive Test for SARS-CoV-2
17 percent of individuals report skin rashes as first presentation and 21 percent report rashes as only clinical sign of COVID-19
By Dermsquared Editorial Team | | June 16, 2021
Risk for Some Adverse Pregnancy Outcomes Up With Hidradenitis Suppurativa
In fully adjusted model, women with hidradenitis suppurativa have increased odds of spontaneous abortion, GDM, C-section
By Dermsquared Editorial Team | | June 16, 2021
Higher BMI Linked to Increased Risk for Developing Psoriasis
Hazard ratio increased for overweight, obese class 1, obese class 2/3 compared with those with BMI <25.0 kg/m
By Physician's Briefing Staff | | June 16, 2021
FDA Approves StrataGraft for Deep Partial-Thickness Thermal Burns
Data show StrataGraft helps reduce the amount of healthy skin needed for grafting
By Physician’s Briefing Staff | | June 16, 2021
Are Women Absorbing Toxins From Their Makeup?
By Physician’s Briefing Staff
By Dennis Thompson (HealthDay News) | | June 15, 2021
Third Dose of COVID Vaccine Boosts Protection in Transplant Recipients
By Physician’s Briefing Staff
By Robert Preidt (HealthDay News) | | June 15, 2021
Narrowband UVB, Topical Steroid Combo Superior for Vitiligo
Combination treatment superior to topical corticosteroids alone, but target patch treatment success only 27 percent with combination
By Dermsquared Editorial Team | | June 09, 2021
SARS-CoV-2 Not Detected in Surgical Electrocautery Plume
No virus was recovered from electrocautery performed using cell titer glow measurement for replicating virus
By Dermsquared Editorial Team | | June 09, 2021
Second-Opinion Strategy Analyzed for Cutaneous Melanocytic Lesions
Decision-analytic model shows selective second-opinion strategy could increase diagnostic accuracy, decrease population-level costs
By Physician’s Briefing Staff | | June 09, 2021
Barriers to Physician Skin Exam ID'd for Young Melanoma Survivors
Barriers to health care access linked to increased odds of suboptimal physician skin examination adherence
By Physician’s Briefing Staff | | June 09, 2021
Gap Between Mortality in Rural and Urban Areas Has Increased
Difference increased in age-adjusted mortality rates between large metropolitan areas, rural areas from 1999 to 2019
By Physician’s Briefing Staff | | June 08, 2021
Drop in Kawasaki Disease Seen During the COVID-19 Pandemic
Incidence decreased sharply after implementation of nonpharmaceutical interventions, such as mask wearing; seasonal pattern absent
By Physician’s Briefing Staff | | June 08, 2021
Real-World Study Shows Power of Pfizer, Moderna Vaccines to Prevent COVID-19
Symptomatic and asymptomatic infection reduced by 81 percent after partial vaccination and by 91 percent after full vaccination
By Physician’s Briefing Staff | | June 08, 2021
Dermatologists Receptive to AI, AuI for Diagnosis of Skin Lesions
Implementation challenges include disruption of the human physician-patient relationship, threats to accuracy
By Dermsquared Editorial Team | | June 02, 2021
Review Links Topical Calcineurin Inhibitors With Lymphoma Risk
No association seen between topical calcineurin inhibitor use and cancer overall compared with nonactive comparators
By Dermsquared Editorial Team | | June 02, 2021
NIH Starts Trial Assessing 'Mix & Match' COVID Vaccine Approach
By Physician’s Briefing Staff | | June 02, 2021
Telehealth Is Growing in Use, Acceptance Among Americans: Poll
By Robert Preidt (HealthDay News) | | June 01, 2021
ASCO: Nivolumab, Relatlimab Combo Slows Advanced Melanoma
Median progression-free survival of 10.1 versus 4.6 months seen among those receiving combo versus nivolumab alone, respectively
By Physician’s Briefing Staff | | May 28, 2021
24 of 1200